Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
242.61
+0.64 (0.26%)
At close: Apr 24, 2025, 4:00 PM
244.01
+1.40 (0.58%)
After-hours: Apr 24, 2025, 7:54 PM EDT

Alnylam Pharmaceuticals Market Cap

Alnylam Pharmaceuticals has a market cap or net worth of $31.41 billion as of April 24, 2025. Its market cap has increased by 59.81% in one year.

Market Cap
31.41B
Enterprise Value
31.46B
1-Year Change
59.81%
Ranking
Category
Stock Price
$242.61

Market Cap Chart

Since June 1, 2004, Alnylam Pharmaceuticals's market cap has increased from $135.00M to $31.41B, an increase of 23,164.89%. That is a compound annual growth rate of 29.78%.

History

DateMarket Cap% Change
Apr 23, 202531.32B3.21%
Dec 31, 202430.35B26.35%
Dec 29, 202324.02B-17.84%
Dec 30, 202229.24B44.16%
Dec 31, 202120.28B34.32%
Dec 31, 202015.10B17.60%
Dec 31, 201912.84B74.32%
Dec 31, 20187.37B-37.48%
Dec 29, 201711.78B266.69%
Dec 30, 20163.21B-59.72%
Dec 31, 20157.98B6.90%
Dec 31, 20147.46B82.96%
Dec 31, 20134.08B326.36%
Dec 31, 2012956.60M174.73%
Dec 30, 2011348.20M-16.32%
Dec 31, 2010416.10M-43.53%
Dec 31, 2009736.80M-28.05%
Dec 31, 20081.02B-13.48%
Dec 31, 20071.18B71.64%
Dec 29, 2006689.60M94.42%
Dec 30, 2005354.70M136.47%
Dec 31, 2004150.00M11.11%
View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 747.82B
UnitedHealth Group 388.99B
Johnson & Johnson 370.88B
AbbVie 312.74B
Novo Nordisk 276.62B
Abbott Laboratories 223.61B
AstraZeneca 213.42B
Novartis AG 208.99B
Market Cap Rankings